NCT04068896 2025-05-29Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNGM Biopharmaceuticals, IncPhase 1/2 Completed89 enrolled 21 charts
NCT01478685 2019-11-12A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCelgenePhase 1 Completed169 enrolled